Seroepidemiological studies of human papilloma virus (HPV‐1) infections
Authors:
- 15 February 1978
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 21 (2) , 161-165
Abstract
At least two groups of human papilloma viruses can be distinguished serologically: on the one hand HPV 1‐3, which are closely related but differ in the restriction enzyme pattern of their DNA, and on the other hand HPV‐4. The age distributions of patients with warts induced by HPV 1‐3 or by HPV‐4, respectively, differ markedly. HPV 1‐3 predominates between 5 and 15 years of age, whereas HPV‐4 could be isolated more often between the ages of 20‐25 years. The large number of HPV‐1‐3‐induced warts in children is paralleled by a high percentage of HPV‐1 antibody‐positive sera in the same age group (about 50%). With increasing age the percentage of HPV‐1 antibody‐positive sera declines gradually. This pattern of seroreactivity was compared to that of patients with various papillomas and with several malignant tumors. There is no evidence to suggest a link between HPV 1‐3 and condylomata acuminata, laryngeal papillomas or any of the malignant tumors tested.Keywords
This publication has 15 references indexed in Scilit:
- Human papilloma viruses (HPV): Characterization of four different isolatesVirology, 1977
- Human papilloma virus DNA: physical mapping and genetic heterogeneity.Proceedings of the National Academy of Sciences, 1976
- Wart-Associated Antigens. II. Human Immunity to Viral Structural ProteinsJournal of Investigative Dermatology, 1973
- STUDY OF REGRESSING WARTS BY IMMUNOFLUORESCENCEThe Lancet, 1973
- Antibodies to Epstein‐Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemiaInternational Journal of Cancer, 1973
- Serological studies in a student population prone to infection with human papilloma virusEpidemiology and Infection, 1972
- Elevated antibody titers to epstein-barr virus in Hodgkin's diseaseCancer, 1971
- FURTHER INFORMATION ON THE ANTIBODY RESPONSE TO WART VIRUSThe Lancet, 1966
- ANTIBODY TO WART VIRUS IN HUMAN SERA DEMONSTRATED BY ELECTRON MICROSCOPY AND PRECIPITIN TESTSThe Lancet, 1965
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963